$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$123.35M
Market Cap
-
P/E Ratio
-2.38
EPS
$4.44
52 Week High
$1.01
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in New York, focused on developing innovative small molecule therapies for cancer treatment through precision medicine. The company is advancing a promising pipeline that targets critical pathways involved in tumor growth and resistance, addressing significant unmet medical needs in oncology. Zentalis's strategic approach and commitment to innovation position it as a potential leader in the biopharmaceutical industry, presenting an appealing investment opportunity for institutional investors seeking exposure to cutting-edge cancer therapies.
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD